baber/WOPTO huggingface dataset:
Patent DE-69109772-D1 (DE)
Inventor: TYRODE ALAIN
IPC: G01N33/00
Filed: 1991-08-01
Granted: 1995-06-22
Abstract: The method involves vibrating the piece and detecting disturbances in the vibrations. The device for applying this method comprises a vibrator (21) fitted with an orientable clamp (22) in which the piece (23) is fixed for testing. An accelerometer (34) fixed to the vibrating support (30) of the clamp delivers an output signal to an electronic circuit which suppresses the low frequencies and operates lamps to indicate acceptance or rejection of the piece. The orientation of the clamp may be modified during testing. 
<IMAGE>
Patent DE-69109998-D1 (DE)
Inventor: LONG ERNEST
IPC: B01L3/02
Filed: 1991-03-21
Granted: 1995-06-29
Abstract: There is described a fluid dispensing system which includes a pipette assembly adapted for use with disposable pipette tips. To ensure a precise location of a disposable pipette tip on the distal end of the stem of the pipette assembly which holds the pipette tip, a proximal chamber of the pipette tip envelops the distal end of the stem and includes a ledge which encircles an annular region of the stem to form an abutment for the stem and establish a precise distance between the distal end of the stem and the pipette tip orifice. In a preferred embodiment the fluid dispensing system is incorporated in an automated analytical instrument.
Patent DE-69115687-D1 (DE)
Inventor: PADMANABHAN RAMA
IPC: A61K9/00
Filed: 1991-04-15
Granted: 1996-02-01
Abstract: A method for the improved transdermal delivery of ionic drugs by electrotransport is provided, wherein certain fatty acids are applied to the body surface which enhance the penetration of the drugs therethrough.
Patent DE-69122122-D1 (DE)
Inventor: DAVIES MICHAEL
IPC: A61K31/16
Filed: 1991-11-15
Granted: 1996-10-17
Abstract: PCT No. PCT/GB91/02017 Sec. 371 Date May 17, 1993 Sec. 102(e) Date Aug. 30, 1993 PCT Filed Nov. 15, 1991 PCT Pub. No. WO92/08453 PCT Pub. Date May 29, 1992.Compounds of formula (I)    <IMAGE>  (I)  in which R and R' are each separately selected from aliphatic hydrocarbon groups, aryl groups and aliphatic hydrocarbon groups substituted by an aryl group, are of value for use in medicaments for the control of free radical induced damage arising from reperfusion injury in tissue, particularly heart damage.
Patent DE-69127972-D1 (DE)
Inventor: CASSELL MICHAEL
IPC: C09D11/10
Filed: 1991-08-01
Granted: 1997-11-20
Abstract: Disclosed are polymer blends of polyesters or polyesteramides and a styrene polymer. The blends are preferably prepared by polymerizing a styrene monomer in the presence of the polyester or polyesteramide. The blends impart superior water resistance, block resistance, and/or gloss to aqueous inks.
Patent DE-69130959-D1 (DE)
Inventor: GEIGER GORDON H
IPC: C21B13/14
Filed: 1991-10-09
Granted: 1999-04-08
Abstract: A process for the continuous production of an iron-carbon alloy utilizing an enclosed reactor (10) capable of limiting the ingress and egress of atmospheric gases and gas reaction products respectively. A solid mineral material (20) containing iron carbide and at least trace amounts of iron oxide, and having a weight ratio of at least about 2:1 or greater, is fed into a molten bath (12) of metallic material in the reactor (10). The molten metallic material is simultaneously reacted with oxygen at a temperature sufficient to generate carbon monoxide as a reaction product. The oxygen is preferably injected into the molten metallic material to facilitate the reaction of the oxygen with carbon from the iron carbide to form the carbon monoxide. The carbon monoxide subsequently enters a vapor space (17) of the reactor (10) above the molten bath (12), and further reacts with oxygen to generate carbon dioxide and heat. Products of the described method are also disclosed including a continuous supply of molten iron-carbon alloy. The system or equipment utilized in the present process is also disclosed.
Patent DE-69131045-D1 (DE)
Inventor: CHAMBARD RENE
IPC: C04B28/02
Filed: 1991-09-30
Granted: 1999-04-29
Abstract: A composite binder consisting, on the one hand, of an aqueous emulsion of at least one hydrocarbon binder and, on the other hand, of at least one hydraulic binder, which is characterised in that it also contains at least one adjuvant intended to control the rate of setting of the hydraulic binder in order to obtain a liquid product with a viscosity of less than 1 Pa s.
Patent DE-69200573-D1 (DE)
Inventor: THIBAULT JEAN-JACQUES
IPC: F23C13/00
Filed: 1992-06-15
Granted: 1994-12-01
Abstract: Heating device comprising a catalytic burner (1) and a thermal receiver (2) consuming at least a part of the heat generated by the catalytic burner, the latter comprising a member (3) for ejection of a flow of combustible gas, a member (4) for admixing primary air to said flow to obtain a mixture to be burned, a chamber (5) for distribution of said mixture, and a structure (6) for catalytic combustion, traversed by the mixture, from its upstream face (6a) in association with the distribution chamber (5) to its downstream face (6b) which discharges the combustion fumes, characterised in that, the radiating front (10) of combustion without flames being situated when operating close to the upstream face of the structure for catalytic combustion, the thermal receiver (2) extends opposite the upstream face (6a) of the catalytic structure (6), over virtually the entire surface of the latter, so as to receive the thermal energy emitted by the radiating front, and said receiver is arranged and constructed to dissipate, on the opposite side (2b) to the upstream face (6a) of the catalytic structure, at least 30% of the thermal energy received by radiation from the radiating front. 
<IMAGE>
Patent DE-69205731-D1 (DE)
Inventor: CEROFOLINI GIANFRANCO
IPC: G21B1/03
Filed: 1992-06-09
Granted: 1995-12-07
Abstract: Neutral deuterium-deuterium fusion is accomplished by bombarding a target constituted by a light deuterated compound with heavy molecular ions obtained by breaking down transition metal carbonyls.
Patent DE-69209915-D1 (DE)
Inventor: HAINES ROBERT CHRISTOPHER
IPC: A63B59/00
Filed: 1992-07-09
Granted: 1996-05-23
Abstract: A striking implement comprises a handle portion (8) and a striking portion, in which the striking implement is discontinuous in that it comprises two parts (9,10) one part including the striking portion and the other part including the handle portion (8) or a part thereof, the said two parts (9,10) having complementary formations (12,13) which are assembled to overlap axially with a vibration-damping material (11) interposed between and bonded to said formations (12,13), whereby the two parts are inseparably connected together but the vibration-damping material (11) mechanically isolates one from the other. <IMAGE>
Patent DE-69222017-D1 (DE)
Inventor: ANDRE LEE R
IPC: B29C31/06
Filed: 1992-12-17
Granted: 1997-10-09
Abstract: A stacker-cutter-weigher apparatus for supplying a continuous supply of a product having a preselected weight which comprises extruding a continuous stock of polymeric material (15) having a substantially stable cross-sectional area, cutting the stock into finite sections (29), and placing the sections on a scale (38). The measured weight is sensed by a central control which adjusts the length of the next section so as to adjust the weight thereof. A further adjustment occurs as each section is placed on the scale (38). This provides a final product having a substantially preselected weight.
Patent DE-69223766-D1 (DE)
Title: Bis(ethylendithiolo)tetrathiafulvalen-metallcyanid-komplex
Inventor: MORI HATSUMI
IPC: H01L39/12
Filed: 1992-09-17
Granted: 1998-02-05
Abstract: Five novel organic substances comprising a combination of bis(ethylenedithiolo)tetrathiafulvalene (hereinafter referred to as BEDT-TTF) with a metal cyanate anion, i.e. (BEDT-TTF)4[Ni(CN)4]H2O: bis(ethylenedithiolo)-tetrathiafulvalene tetracyanonickelate monohydrate, (BEDT-TTF)4[Pt(CN)4]H2O, (BEDT-TTF)[Pd(CN)2], (BEDT-TTF)4[Pd(CN)4]H2O, and (BEDT-TTF)4[Pd(CN)4]. The BEDT-TTF functions as a donor in the crystals of the above substances to thereby impart characteristics as insulator, metal or superconductor. The development of superconductivity can be expected for a BEDT-TTF compound having a coordinated metal cyanate anion which can readily build such a large skeleton as to increase the effective volume, such as the above substances. <IMAGE>
Patent DE-69224988-D1 (DE)
Inventor: INMAN JOHN
IPC: C07K1/107
Filed: 1992-06-10
Granted: 1998-05-07
Abstract: A new amino acid derivative, N alpha -tert-butoxycarbonyl-Ne-(N-bromoacetyl- beta -alanyl)-L-lysine (BBAL), has been synthesized as a reagent to be used in solid-phase peptide synthesis for introducing a side-chain bromoacetyl group at any desired position in a peptide sequence. The bromoacetyl group subsequently serves as a sulfhydryl-selective cross-linking function for the preparation of cyclic peptides, peptide conjugates and polymers. BBAL residues are stable to final HF deprotection/cleavage. BBAL peptides can be directly coupled to other molecules or surfaces which possess free sulfhydryl groups by forming stable thioether linkages. Peptides containing both BBAL and cysteine residues can be self-coupled to produce either cyclic molecules or linear peptide polymers. Such peptide derivatives are useful in preparing potential peptide immunogens, vaccines and therapeutics, and for substances such as peptides linked to polymers, plastics, enamels and ceramics.
Patent DE-69225421-D1 (DE)
Inventor: PADFIELD JOHN MALCOLM
IPC: A61K47/38
Filed: 1992-03-02
Granted: 1998-06-18
Abstract: A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
Patent DE-69227318-D1 (DE)
Inventor: BAHIA HARDEV
IPC: A61L15/28
Filed: 1992-12-09
Granted: 1998-11-19
Abstract: Carboxymethyl cellulose fiber having a degree of substitution of at least 0.1, preferably 0.2-0.5, carboxymethyl groups per glucose unit is derived from solvent-spun cellulose fiber, for example by reaction with a strong alkali and a monochloroacetate reagent. The fiber has an absorbency of at least 8 grams, usually at least 15 grams, 0.9% saline solution per gram of fibre and a tenacity of at least 10, usually at least 15, cN/tex. It can be used for absorbent personal products.
Patent DE-69308332-D1 (DE)
Inventor: ROBLES GUILLERMO
IPC: G11B23/26
Filed: 1993-11-24
Granted: 1997-04-03
Abstract: A new generation magnetic tape cartridge of the type having a leader block is provided along with a new generation leader block pin so as to prevent interlocking with respect to prior art leader blocks and leader block pins. The magnetic tape cartridge is a generally rectangular container which has four corners. One of the corners of the container is beveled and is provided with a well to receive the new generation leader block in a nested position. The new generation leader block has a notch which has top, bottom and middle portions. A cross section of the middle portion of the notch is smaller than the cross section of the bottom portion of the notch, and the cross section of the top portion of the notch is smaller than the cross section of the middle portion of the notch. The cross section of the bottom portion of the notch is defined by a circular arc of more than 180 DEG  for receiving and capturing a new generation leader block pin. The top portion of the notch in the block is fashioned to confine the new generation leader block pin to a predetermined amount of lateral movement. The configurations of the notch of the new generation leader block and the new generation leader block pin are fashioned to prevent interlock with prior art reader blocks and leader block pins.
Patent DE-69314041-D1 (DE)
Inventor: HUMPHREY STEPHEN
IPC: C07D239/42
Filed: 1993-07-21
Granted: 1997-10-23
Abstract: Cyanoguanidine compounds of Formula I and its pharmaceutically acceptable acid addition salts   <IMAGE>   wherein R1 is hydrogen or methyl; R2 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C5 cycloalkyl, C3-C5 cycloalkenyl hydroxy methyl, methoxy-C1-C5 alkyl, or R1 and R2 are combined to form a C3-C6 carbocyclic ring; R3 and R4 are each independently selected to be hydrogen, C1-C4 alkyl, F, Cl, Br, I or CF3; R5 is hydrogen, F or Cl; R6 is hydrogen, -NH2, -NHCH3, -NHC2H5, -NHCH(CH3)2, -N(CH3)2, -N(C2H5)2, NH(CH2)m- OC1-C3 alkyl (where m is 2 or 3), -NHC(O)C1-C3 alkyl, Cl or Br; and n is 0 or 1. The compounds of Formula I are potassium channel blockers useful in the treatment of cardiovascular disorders such as congestive heart failure and hypertension and as a diuretic.
Patent DE-69322509-D1 (DE)
Inventor: AHONEN JALO
IPC: G01R27/06
Filed: 1993-12-29
Granted: 1999-01-21
Abstract: PCT No. PCT/FI93/00563 Sec. 371 Date Aug. 30, 1994 Sec. 102(e) Date Aug. 30, 1994 PCT Filed Dec. 29, 1993 PCT Pub. No. WO94/16335 PCT Pub. Date Jul. 21, 1994.An arrangement for measuring the condition of a receiver antenna at a base station, utilizing an antenna amplifier positioned in connection with an antenna apart from other base station equipments, e.g., at a mast. A measuring signal is generated in connection with the other base station equipments at a frequency outside the frequency band used for radio traffic and applied through an antenna line to the antenna amplifier, in which the measuring signal is converted to the actual measuring frequency within the frequency band intended for the radio traffic.
Patent DE-69324192-D1 (DE)
Inventor: YAMAMOTO KOSUKE
IPC: B41J2/01
Filed: 1993-06-11
Granted: 1999-05-06
Abstract: A recovery mechanism for ink ejection recovery of an ink jet device includes a wiping member (35) for wiping a surface having an ink ejection outlet by relative movement between the wiping member and the surface; and a rubbing member (40) for rubbing the wiping member by relative movement therebetween, the rubbing member being heated at a predetermined temperature. <IMAGE>
Patent DE-69328084-D1 (DE)
Inventor: GOLDENBERG YOAV
IPC: H03K5/13
Filed: 1993-12-22
Granted: 2000-04-20
Abstract: A clock is phase shifted by an amount controlled by the value of a control signal by establishing at least several discrete delay times to be imposed on the clock. The control signal value controls selection of the imposed discrete delay time. An analog-to-digital converter of a phase locked loop responds to intelligence representing variable phase bits and the selected phase shifted clock to control the signal value. The selected replica is derived by at least several cascaded substantially equal time delay units. In one embodiment, a multiplexer responds to the clock, and the signal value, which is Gray coded, to control connections from one of the delay units to an output terminal. In another embodiment, the number of cascaded delay units interposed between the clock and an output terminal is controlled by the signal value.
Patent DE-69400265-D1 (DE)
Inventor: SISLEGARD LARS-OTTO
IPC: B30B15/24
Filed: 1994-02-12
Granted: 1996-08-01
Abstract: An arrangement for controlling the thickness of board products (4) during the pressing process in a board press with a first and a second press table (5,2) where the pressing force is transferred by several hydraulic press cylinders (1). A number of hydraulic position valves (7) are arranged in spaced relationship on both sides of the press on the first press table (5). Corresponding push-rods (9) are arranged on the second press table (2). The push-rods are adjustable, and a common shifting motor (12) is provided for simultaneous adjustment of the push-rods (9). <IMAGE>
Patent DE-69407430-D1 (DE)
Inventor: FLYNN GARY A
IPC: C07C233/14
Filed: 1994-10-20
Granted: 1998-01-29
Abstract: The present invention relates to a novel enantiospecific process for preparing (S)-1-[2(S)-(1,3-dihydro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl ]-1,2,3,4-tetrahydro-2-pyridine-carboxylic acid methyl ester which is a useful intermediate in the preparation of [4S-[4 alpha , 7 alpha (R*), 12b beta ]]-7-[(1-oxo-2(S)-thio-3-phenylpropyl) amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo-pyrido[2,1-a][2]benzazepine-4-carboxylic acid and [4S-[4 alpha , 7 alpha (R*), 12b beta ]]-7-[(1-oxo-2(S)-acetylthio-3-phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo-pyrido[2,1-a][2]benzazepine-4-carboxylic acid and pharmaceutically acceptable salts thereof which is useful as an inhibitor of enkephali nase and angiotensin converting enzyme and to novel intermediates thereof.
Patent DE-69413958-D1 (DE)
Inventor: PFISTER JURG
IPC: C07D213/65
Filed: 1994-04-13
Granted: 1998-11-19
Abstract: 10,11-Methanodibenzosuberane derivatives, i.e., the compounds of Formula I: <CHEM>  wherein:   A is -CH2-CH2-, -CH2-CHR<a>-CH2-, where R<a> is H, OH or lower acyloxy of the formula -O-C(=O)-R', wherein R' is a cyclic, branched or straight chain monovalent alkyl radical of 1-6 carbon atoms, or -CH2-CHR<a>-CHR<b>-CH2-, where one of R<a> or R<b> is H, OH, or lower acyloxy of the formula -O-C(=O)-R', wherein R' is a cyclic, branched or straight chain monovalent alkyl radical of 1-6 carbon atoms, and the other is H;   R<1> is H, F, Cl or Br;   R<2> is H, F, Cl or Br; and R<3> is heteroaryl excluding heteroaryl with 2 condensed rings and 1 to 3 heteroatoms selected from the group consisting of N, O and S; or phenyl optionally substituted with F, Cl, Br, CF3, CN, NO2 or OCHF2; and the pharmaceutically acceptable salts thereof, are useful chemosensitizing agents, e.g., for cancer chemotherapy, particularly for treating multidrug resistance.
Patent DE-69429522-D1 (DE)
Inventor: JANZEN ERNST
IPC: A61L27/00
Filed: 1994-09-07
Granted: 2002-01-31
Abstract: Injectable implant compositions for soft tissue augmentation comprise elastin and collagen and a biocompatible carrier. An injectable implant composition for soft tissue augmentation is derived from the ligamentum nuchae which has been treated to remove non-collagenous and non-elastinous proteins. Methods of making an injectable implant composition for soft tissue augmentation from the ligamentum nuchae are described.
Patent DE-69429783-D1 (DE)
Inventor: GORDON JULIAN
IPC: B01J3/00
Filed: 1994-11-22
Granted: 2002-03-14
Abstract: A method and apparatus for collecting a cell sample from a liquid specimen utilizes a collection receptacle in which the specimen is deposited, with a filter media being place in communication with a discharge port in the collection receptacle and a transfer device for drawing specimen from the collection receptacle and through the filter for capturing the cellular component of the specimen on the filter media for defining a cell sample for analysis. The collection receptacle, filter media and carrier therefor and the transfer device may be supplied in kit form for use in a clinical environment. A hypobaric vessel may be used and the transfer device and this vessel may also serve as a disposal receptacle for the liquid specimen passed through the filter media.
Patent DE-69432935-D1 (DE)
Inventor: RITTER A
IPC: C09J7/02
Filed: 1994-02-15
Granted: 2003-08-14
Abstract: A method for applying pressure sensitive adhesive to a substrate, in which the adhesive is deposited on a transfer surface, such as a circulating transfer belt, dried, and subsequently transferred to a plurality of overlapping sheets. The sheets are preferably coated with a primer or a low adhesion backsize, or both, prior to application of the adhesive. <IMAGE>
Patent DE-69433933-D1 (DE)
Inventor: NICOLAU CLAUDE
IPC: A61K35/18
Filed: 1994-03-23
Granted: 2004-09-09
Abstract: The present invention relates to a method and apparatus for the encapsulation of biologically-active substances in red blood cells, characterized by an optionally automated, continuous-flow self-contained electroporation system (10), as shown in the figure which allows withdrawal of blood from a patient (11), separation of red blood cells (44), encapsulation of a biologically-active substance in the cells (72), and optional recombination of blood plasma and the resulting modified red blood cells (96), thereby producing blood with modified biological characteristics. The present invention is particularly suited for use to encapsulate allosteric effectors of hemoglobin, thereby reducing the affinity of erythrocytes for oxygen and improving the release of oxygen from erythrocytes in tissues.
Patent DE-69508759-D1 (DE)
Inventor: SORENSEN LONE
IPC: C03B1/02
Filed: 1995-06-14
Granted: 1999-05-06
Abstract: A mineral charge containing briquettes is melted in a furnace to form a melt from which man-made vitreous fibres are formed. The briquettes are novel and are compression moulded briquettes of particulate inorganic material bonded by a bonding agent which comprises molasses, usually with lime. The briquettes may include vegetable or other fibres to improve green strength.
Patent DE-69509329-D1 (DE)
Inventor: LEFEVRE FANNY
IPC: C02F3/30
Filed: 1995-09-18
Granted: 1999-06-02
Abstract: In regulating the aeration of a biological treatment of waste water, using (i) a step of aerobic elimination of carbon, (ii) a step of aerobic nitrification, and (iii) a denitrification step in absence of oxygen, the oxidn.-redn. potential in a treatment system is measured continuously, the curve of development of this potential as a function of time is established, and the deriv. is calculated. When this deriv. tends towards 0, the deriv. and the value of the potential are correlated, to decide on the start, the continuation or the ending of the aeration.
Patent DE-69532738-D1 (DE)
Inventor: BREWER KEVIN D
IPC: B25C5/02
Filed: 1995-08-09
Granted: 2004-04-29
Abstract: An impact stapler (100) includes an actuator mechanism ((110)) comprising a firing lever (180) pivotally mounted on a stapler housing (102) and operable by an operating lever (160) for raising a striker (112) against the bias of an actuator spring (240). The firing lever (180) has a front tip (190) which is positioned to engage a tab (272) on the striker (112) when the operating lever (160) is actuated to raise the striker (112) and which is shifted laterally to disengage the front tip (190) from the tab (272) to release the striker (112) for actuation by the actuator spring (240) after the striker (112) is raised. The impact stapler (100) includes a resilient finger (292) for shifting the firing lever (180) laterally to a rest position with the front tip (190) underneath the tab (272) on the striker (112). A stop (295) engages the firing lever (180) in its rest position to limit the bending of the resilient finger (292) and to locate the front tip (190) in a predetermined lateral position relative to the tab (272) on the striker (112). <MATH>
Patent DE-69533130-D1 (DE)
Inventor: LILJESTROEM PETER
IPC: C12N7/00
Filed: 1995-03-30
Granted: 2004-07-15
Abstract: The present invention is related to polynucleotide molecules and to their use for production of desired products after introduction into human or animal cells. In addition, the present invention is concerned with pharmaceutical compositions comprising said polynucleotide molecules and their use in prophylactic or therapeutic treatment methods. The present invention is also related to use of such polynucleotide molecules in animals to achieve expression of desired products, which can be recovered from the animal but do not give rise to any beneficial, e.g. therapeutic, activity in the animal. More specifically, the present invention is directed to alphaviruus cDNA vectors comprised of recombinant cDNA consisting of cDNA derived from an alphavirus and heterologous, i.e. foreign, cDNA encoding a desired substance.